March 24, 2023

Upcoming Events

Constructive Collisions: ARPA-H 

Does the idea of high-potential, high-impact health research excite you? Do you have a $10 million - $30 million idea that could transform biomedical and health research?  

If so, join us for an in-person, on-campus event that will include structured networking opportunities to connect researchers with big ideas relevant to ARPA-H across the Emory community. No idea is too big for ARPA-H. All interested Emory researchers are encouraged to attend. 


The first Mission Office Directors and Program Managers have been named. Click the links below to find out more about these key ARPA-H team members.  

For more information on ARPA-H focus areas, visit the ARPA-H Research page.   

Date: April 20, 2023

Time: 12-2 pm

Location: R. Randall Rollins Building, 8th Floor 1518 Clifton Rd. NE Atlanta, 30322

Registration for this event closes April 13th. 


Featured Opportunities

NIH Director’s Pioneer Award Program (DP1 Clinical Trial Optional) (RFA-RM-23-004)

The NIH Director’s Pioneer Award Program supports individual scientists of exceptional creativity who propose highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH.

For the program to support the best possible researchers and

research, applications are sought which reflect the full diversity of the nation’s research workforce.

Thus, individuals from all backgrounds and from the full spectrum of eligible institutions in all geographic locations are strongly encouraged to apply to this Funding Opportunity Announcement.

In addition, applications in all topics relevant to the broad mission of NIH are welcome, including, but not limited to, topics in the behavioral, social, biomedical, applied, and formal sciences and topics that may involve basic, translational, or clinical research.

To be considered pioneering, the proposed research must reflect substantially different scientific directions from those already being pursued in the investigator’s research program or elsewhere.

The NIH Director’s Pioneer Award is a component of the High-Risk, High-Reward Research (HRHR) Program of the NIH Common Fund.

Deadline for Applications: 9/8/2023

View RFP

Genomic Community Resources (U24 Clinical Trial Not Allowed)

To facilitate genomic research and the dissemination of its products, NHGRI supports both new and existing genomic resources of demonstrated broad value to the research community. Awards under this FOA will support the development and distribution of high-value genomic resources valuable for both basic and clinical genomics research.

Deadline for Applications: 5/25/2023

View RFP

Research Scholars Program in Hematologic Malignancies 

This program supports innovative research from emerging investigators around the world to incorporate new perspectives in our pursuit of scientific understanding and progress.

The program is designed to support both clinical and basic research projects addressing any unmet medical need in Hematologic Malignancies. Areas of research may include but are not limited to:

  • Health inequities and disparities in cancer care
  • Clinical treatment modalities
  • Research to improve Quality of Life (QoL) e.g. adverse events
  • Novel diagnostic, prevention and treatment strategies

Deadline for Applications: 4/14/2023

View Program Brochure

National Science Foundation Incorporating Human Behavior in Epidemiological Models (IHBEM)

Current epidemiological models have proved insufficient to understanding the course of the COVID-19 pandemic, in part, due to human behavioral and social processes that are missing from the models.

These processes include structural characteristics such as differential living conditions and patterns of social interaction, and behavioral characteristics such as responsiveness to incentives and information by different segments of the population.

As a result, the mathematical models and, tools for model analyses and simulations that were developed to respond to the pandemic were not as effective or useful as they could have been.

The IHBEM program is motivated by the urgent need to provide more reliable modeling tools to inform decision making and to evaluate public health policies during pandemics and other public health crises, with the premise that important advances may be made by incorporating human behavioral and social processes in mathematical epidemiological models.

The goal of this program is to minimize unintended outcomes of public health interventions.

Deadline for applications: Submission window: April 3 - April 14, 2023

View RFP

Substance Use Prevention Services in Primary Care Challenge

The United States is experiencing a significant behavioral health crisis, putting substantial strain on the health care system.

Primary care practices are one potential setting in which to address this crisis, but primary care providers (PCPs) face substantial barriers in identifying individuals who may be at risk for substance use and delivering evidence-based prevention interventions to reduce the risk for use.

This Challenge seeks creative, visionary, and actionable plans to implement substance use prevention interventions in primary care. Winners will receive prizes of up to $25,000, and NIDA encourages the winners to utilize the awards to support the implementation of substance use prevention services in those primary care practices. 

Open until: 5/19/23

View Guidelines


ARPA-H Dash competition seeks advanced health concepts!

The ARPA-H Dash is a collaborative online competition open to bold thinkers across health, scientific, and technology communities, as well as the general public. 

The ARPA-H Dash will use a bracket format and online discussion, debate, and voting to narrow competition submissions to quarterfinalists, semifinalists, finalists, and a champion idea during March and April 2023. Sixty-four submissions will be grouped within ARPA-H’s strategic focus areas (above). Cash prizes of up to $15,000 will be awarded to ideas that reach competition quarterfinals and beyond, as well as the chance for further development with ARPA-H Program Managers.  

Ideas will be accepted through the online portal between March 29 and April 7, 2023

Program Information


Biomedical Technology Optimization and Dissemination Center (BTOD)(RM1-Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) encourages applications for NIGMS Biomedical Technology Optimization and Dissemination (BTOD) Centers to support late-stage technology optimization and sustainable dissemination of the technology to the wider biomedical research community.

A BTOD Center should be at the leading edge of its field with respect to both technology development and engagement with relevant research communities.

Deadline: 5/26/2023

Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities (R01 Clinical Trial Optional)

This funding opportunity announcement (FOA) seeks to support research that examines the impact of leveraging health information technology (health IT) to reduce disparities in access to and utilization of health care services, patient-clinician communication, and health outcomes for populations that experience health disparities in the U.S.

Deadline: 6/5/2023

Infectious Disease

Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Flaviviridae and Togaviridae (U19 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) solicits applications to participate in the Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network.

The purpose of this FOA is to establish comprehensive, cooperative basic and translational research Centers to carry out in-depth research on prototype members of select virus families that have the potential to emerge as pandemic pathogens.

The goal of these Centers will be to develop vaccine and monoclonal antibody strategies for prototype pathogen(s) that can be applied to closely related family members based on shared functional and structural properties. This FOA solicits for Centers proposing research on virus families from Flaviviridae and Togaviridae to be part of the ReVAMPP Network.

Deadline: 6/8/2023

Identification and Characterization of Bioactive Microbial Metabolites for Advancing Research on Microbe-Diet-Host Interactions (R01 Clinical Trial Not Allowed)

The purpose of the Funding Opportunity Announcement is to invite applications to identify and characterize microbial metabolites that will establish causal associations between microbial metabolism and host health and disease.

Data acquired through this initiative will be used to create a knowledgebase of microbial metabolites and associated functions that will be provided to the research community.

Deadline: 6/22/2023

Brain Health

BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed) (RFA-NS-21-026)

Understanding the dynamic activity of brain circuits is central to the NIH BRAIN Initiative.

This FOA seeks applications for proof-of-concept testing and development of new technologies and novel approaches for recording and modulation (including various modalities for stimulation/activation, inhibition and manipulation) of cells (i.e., neuronal and non-neuronal) and networks to enable transformative understanding of dynamic signaling in the central nervous system (CNS).

This FOA seeks exceptionally creative approaches to address major challenges associated with recording and modulating CNS activity, at or near cellular resolution, at multiple spatial and/or temporal scales, in any region and throughout the entire depth of the brain.

It is expected that the proposed research may be high-risk, but if successful, could profoundly change the course of neuroscience research.

Deadline: 5/1/2023

Blood Brain Barrier Response to Antibodies Targeting Beta-Amyloid (R01 - Clinical Trial Not Allowed)

This funding opportunity announcement (FOA) solicits applications designed to increase understanding of cellular and molecular mechanisms that can be targeted to protect the blood-brain barrier (BBB), and thus brain blood vessels, during therapeutic interventions that target beta-amyloid.

This includes applications that promote the discovery of cellular and molecular mechanisms that underlie brain blood vessel responses to passive anti-beta-amyloid immunotherapy that result in amyloid-related imaging abnormalities and other potentially adverse cerebrovascular responses.

Deadline: 6/2/2023


Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit (U24 Clinical Trial Not Allowed)

The purpose of this FOA is to solicit applications for the Data Management and Coordination Unit (DMCU), one of the two components of the Precompetitive Collaboration on Liquid Biopsy for Early-Cancer Assessment Consortium (LBC).

LBC is an Academic-Industrial Partnership program to develop and validate liquid biopsy technologies for early-cancer detection, risk assessment, and/or for distinguishing cancer from benign disease or aggressive from indolent cancers.

The DMCU will be responsible for: (1) Consortium Coordination; (2) Statistical and Computational Analysis Support; and (3) Data Management and Protocol Development.

Deadline: 5/5/2023

Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)

The purpose of this Funding Opportunity Announcement (FOA) is to invite exploratory/developmental research grant applications (R21) for innovative informatics methods and algorithms to improve the acquisition, analysis, visualization, or interpretation of data across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities.

As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Program, the emphasis of this FOA is on supporting the development of novel informatics capabilities that involve a high degree of innovation that have the potential to accelerate or enhance research.

Deadline: 6/13/2023

Global Health

Exploratory Grants for Climate Change and Health Research Center Development (P20 Clinical Trial Optional)

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit P20 planning grant applications for Climate Change and Health Research Centers (CCHRCs).

This program will support the development of a transdisciplinary research environment to sustain a program of fundamental and applied research to examine the impacts of climate change on health and to develop action-oriented solutions to protect the health of individuals, communities, and nations from the hazards posed by climate change.

This opportunity will allow development of new research teams collaborating with communities and other partners to develop projects that generate data that will build or expand research capacity across a range of thematic scientific areas in support of the four core elements of the NIH’s Initiative in climate heath research: health effects research, health equity, intervention research, and training and capacity building

Deadline: 5/1/2023

Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed)

This funding opportunity announcement (FOA) is intended to support novel environmental health research in which an unpredictable event or policy change provides a limited window of opportunity to collect human biological samples or environmental exposure data.

The primary motivation of the FOA is to understand the consequences of natural and human-made disasters, emerging environmental public health threats, and policy changes in the U.S. and abroad.

A distinguishing feature of an appropriate study is the need for rapid review and funding, substantially shorter than the typical NIH grant review/award cycle, for the research question to be addressed and swiftly implemented.

Deadline: 6/1/2023

Social Justice / DEI

FDA OMHHE Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed

The purpose of this funding opportunity announcement (FOA) is to fund innovative research that will strengthen and advance minority health and health equity research.

Areas of interest include:

Proposals that focus on advancing equity in clinical trials by supporting efforts to advance diversity in clinical trials, equitable data efforts by increasing data available on diverse groups including, but not limited to, ethnicity, race, age, disability and geography, and equity of voices by increasing understanding of diverse patient perspectives, preferences, and unmet needs.

Deadline: 5/8/2023

Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)

The NIH Research With Activities Related to Diversity (ReWARD) Program's overarching goal is to enhance the breadth and geographical location of research and research-related activities supported by NIH.

The ReWARD program  provides support for the health-related research of scientists who are making a significant contribution to Diversity, Equity, Inclusion, and Accessibility (DEIA) and who have no current NIH research project grant funding.

The ReWARD program provides funding for both the scientific research and the DEIA activities of investigators.

The grant will support scientific research in areas related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) and ongoing DEIA activities focused on enhancing diversity in the biomedical research enterprise within the United States and territories.

Deadline: 6/5/2023

Finding Funding

Funding Opportunities Calendar 

A comprehensive archive of past, present, and upcoming opportunities can be found on the SVPR funding calendar. Click the link below to view.

Link to SVPR Funding Calendar

Limited and Internal Competitions through InfoReady

Universities involved in research often need to run competitions for grant funding, whether for internal grant dollars or limited submission opportunities through external sponsors.

If you are interested in submitting a proposal to a funding opportunity with an institutional limitation, please check InfoReady to see if it is listed first. If it is not there, please email and include the funding opportunity number, title, and due date.

Link to InfoReady

Search Tool for Corporate and Foundation Funding Opportunities

The Office of Corporate Relations and the Office of Foundation Relations have teamed up to create this resource site to provide a curated list of current funding opportunities and other resources. This site will help promote connections between Emory colleagues and corporate/foundation partners.

Link to SharePoint Search Tool


Free access available with Emory Email address. Formally IRIS. Provides access to the University Community to conduct funding searches. The database is provides funding opportunities for the physical and life sciences, social sciences, arts, and humanities.

Link for More Information is a central storehouse for information on over 1,000 grant programs from over 27 federal agencies. Interested applicants can search for relevant funding opportunities by Keyword or Category or browse opportunities by agency. The portal is also a central source to apply for federal grants. Information on the processes for proposal submission through can be found in Proposal Submission.

Foundation Directory

Free access available through Databases@Emory. This database, produced by the nation's leading authority on philanthropy, includes extensive program details for thousands of leading foundations; detailed application guidelines for more than 7,000 grants; and a searchable file of approximately half a million grants.

Link for More Information

Visit our website